VSH Earnings

VSH reported its earnings on 2026-02-04, showcasing a revenue of 800.92M against an estimate of 790.00M, resulting in a 1.38% surprise. The EPS was 0.01, surpassing the expected 0.02 by -50%. The stock experienced a -4.24% price change on the earnings day and a -6.08% change over the next five days, reflecting market reactions to the results.

Following VSH's earnings announcement on 2026-02-04, the stock price moved by -4.24% on the day of the release. Over the subsequent five days, it saw a -6.08% change. Historically, VSH's stock price tends to shift by an average of 5.05% in the 10 days leading up to earnings and 1.9% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate VSH's annual revenue to reach 799.69M, while the EPS is projected at 0.10. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between VSH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, VSH's stock price typically moves by 5.05% in the 10 days before its earnings and 1.9% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.10 and revenue of 799.69M.

The earnings call presents a mixed picture. While there are positive aspects like strong demand in AI-related applications and stable revenue in healthcare, there are concerns about rising SG&A expenses and declining EBITDA margin. The Q&A reveals cautious optimism with mid-single-digit growth expectations and price adjustments to counter cost pressures. However, uncertainties around share gains, M&A, and memory pricing impact add ambiguity. Given the company's market cap and the balanced positives and negatives, the stock price is likely to remain neutral, with limited short-term movement.